期刊文献+

抗磷脂综合征并发颅内静脉窦血栓临床特点 被引量:8

Clinical Manifestations of Cerebral Venous Sinus Thrombosis in Antiphopholipid Syndrome
下载PDF
导出
摘要 目的探讨抗磷脂综合征(antiphospholipid syndrome,APS)并发颅内静脉窦血栓(cerebral venous sinus thrombosis,CVST)的临床特点,筛查CVST可能高危因素。方法回顾性分析北京协和医院2004年1月至2014年12月期间住院治疗APS患者中并发CVST的临床表现,实验室及影像学检查特点、血栓形成部位以及治疗和结局。结果 APS并发CVST患者14例,女性8例,中位年龄为34.5(22.0,48.5)岁,中位病程3.5(0.9,10.3)个月。12例(85.7%)出现头痛,6例(42.9%)在病程中曾出现意识障碍,8例(57.1%)出现视盘水肿。磁共振静脉血管成像结果显示横窦受累13例(92.9%),乙状窦9例(64.3%),上矢状窦6例(42.9%),下矢状窦4例(28.6%)。APS并发CVST患者补体降低发生率明显高于APS未并发CVST者,差异有统计学意义(57.1%vs.19.0%,P=0.006)。所有患者均接受低分子肝素抗凝、脱水降颅压治疗,2例接受静脉窦内尿激酶溶栓治疗,13例患者接受激素及免疫抑制剂治疗。1例放弃出院,13例患者病情改善,未再出现病情复发。结论 CVST是APS少见中枢神经系统并发症之一,早期诊断难度大,对于无明确诱因的CVST患者需要警惕APS可能性。APS患者出现颅高压相关症状时,应尽早完善头颅影像学评估CVST,做到早期诊断、早期治疗,以改善预后。 Objective To investigate the clinical and neuroimaging characteristics of antiphopholipid syndrome( APS) patients complicated with cerebral venous sinus thrombosis( CVST). Methods Patients with APSCVST admitted to Peking Union Medical College Hospital from January 2004 to December 2014 were enrolled and analyzed retrospectively. Demographic data, age at onset, disease duration, clinical manifestations, imaging characteristics, management and prognosis were collected. Results Fourteen patients were included,in which 8 were female. The median age was 34. 5( 22. 0,48. 5),and the median disease duration was 3. 5( 0. 9, 10. 3). Headache( 85. 7%) was the most common neurological symptoms,followed by altered mental status( 42. 9%). Compared with non-CVST APS patients,APSCVST patients had significantly more frequent of hypocomplementemia( 57. 1% vs. 19. 0%,P = 0. 006).Magnetic resonance venography( MRV) showed that common locations of thrombosis were transverse sinus( 92. 9%), sigmoid sinus( 64. 3%), superior sagittal sinus( 42. 9%),and inferior sagittal sinus( 28. 6%). All patients were treated with anticoagulant therapy,two patients were treated with local intravenous thrombolysis. Conclusion Patients with CVST without definite primary hyper-coagulation status should routinely be tested for antiphospholipid antibodies. Aggressive treatment for the underlying diseases combined with anticoagulant therapy may improve the prognosis of APS patients complicated with CVST.
出处 《中华临床免疫和变态反应杂志》 2016年第1期4-9,共6页 Chinese Journal of Allergy & Clinical Immunology
基金 国家高技术研究发展计划(863计划)(2012AA02A513)
关键词 抗磷脂综合征 颅内静脉窦血栓 颅内压增高 磁共振静脉成像 狼疮抗凝物 抗凝 antiphopholipid syndrome cerebral venous sinus thrombosis intracranial hypertension magnetic resonance venography lupus anticoagulant anticoagulation
  • 相关文献

参考文献16

  • 1Miyakis S,Lockshin MD,Atsumi T,et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J].J Thromb Haemost,2006,4:295-306. 被引量:1
  • 2Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40:1725. 被引量:1
  • 3Miroslav M,Mislav C,Marko R,et al.Antiphospholipid syndrome and central nervous system[J].Clin Neurol Neurosurg,2010,112:602-608. 被引量:1
  • 4Terazzi E,Mittino D,RudàR,et al.Cerebral venous thrombosis:a retrospective multicentre study of 48patients[J].Neurol Sci,2005,25:311-315. 被引量:1
  • 5Stam J.Thrombosis of the cerebral veins and sinuses[J].N Engl J Med,2005,352:1791-1798. 被引量:1
  • 6Ferro JM,Canhao P,Stam J,et al.Prognosis of cerebral vein and dural sinus thrombosis:results of the International Study on Cerebral Vein and Dural Sinus Thrombosis(ISCVT)[J].Stroke,2004,35:664-670. 被引量:1
  • 7王立,陈华,钱敏,周佳鑫,吴庆军,郑文洁,张奉春.系统性红斑狼疮合并颅内静脉窦血栓的临床特点[J].中华临床免疫和变态反应杂志,2014,8(2):113-118. 被引量:9
  • 8Fischetti F,Durigutto P,Pellis V,et al.Thrombus formation induced by antibodies to beta 2-glycoprotein I is complement dependent and requires a priming factor[J].Blood,2005,106:2340-2346. 被引量:1
  • 9Pierangeli SS,Girardi G,Vega-Ostertagm M,et al.Espinola and J.Salmon Requirement of activation of complement C3 and C5 for antiphospholipid antibodymediated thrombophilia[J].Arthritis Rheum,2005,52:2120-2124. 被引量:1
  • 10Shapira I,Andrade D,Allen SL,et al.Brief report:induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab[J].Arthritis Rheum,2012,64:2719-2723. 被引量:1

二级参考文献15

  • 1Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40:1725. 被引量:1
  • 2Miyakis S,Lockshin MD,Atsumi T,et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J].J Thromb Haemost,2006,4:295-306. 被引量:1
  • 3Muscal E,Brey RL.Neurologic manifestations of systemic lupus erythematosus in children and adults[J].Neurol Clin,2010,28:61-73. 被引量:1
  • 4Benseler S,Silverman E.Neuropsychiatric involvement in pediatric systemic lupus erythematosus[J].Lupus,2007,16:564-571. 被引量:1
  • 5Hiraki LT,Benseler SM,Tyrrell PN,et al.Clinical and laboratory characteristics and longterm outcome of pediatric systemic lupus erythematosus:a longitudinal study[J].J Pediatr,2008,152:550-556. 被引量:1
  • 6ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature.The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J].Arthritis Rheum,1999,42:599-608. 被引量:1
  • 7Sultana N,Chowdhury HM,Mahbub S,et al.CVST:A rare presentation of headache mimicking subarachnoid hemorrhage[J].J Med,2009,10:115-118. 被引量:1
  • 8Kimber J.Cerebral venous vinus thrombosis[J].Q J Med,2002,95:137-142. 被引量:1
  • 9Mikdashi J,Handwerger B.Predictors of neuropsychiatric damage in systemic lupus erythematosus:data from the Maryland lupus cohort[J].Rheumatol,2004,43:1555-1560. 被引量:1
  • 10Xu H,Chen K,Lin D,et al.Cerebral venous sinus thrombosis in adult nephrotic syndrome[J].Clin Nephrol,2010,74:144-149. 被引量:1

共引文献8

同被引文献28

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部